Cost-effectiveness of glaucoma interventions in Barbados and Ghana

Optometry and Vision Science

Volumn 88, Issue 1, 2011, Pages 155-163

  Wittenborn, John S ^a   Rein, David B ^a  

^a RTI INTERNATIONAL   (United States)

Author keywords

Barbados; cost effective; developing; Ghana; Glaucoma; simulation; vision

Indexed keywords

BARBADOS; COST EFFECTIVE; DEVELOPING; GHANA; GLAUCOMA; SIMULATION;

COST EFFECTIVENESS; COSTS; DEVELOPING COUNTRIES; DISEASES; ECONOMIC AND SOCIAL EFFECTS; EYE PROTECTION; LASER SURGERY;

OPHTHALMOLOGY;

ADULT; AGED; ARTICLE; BARBADOS; COST BENEFIT ANALYSIS; COST OF ILLNESS; DEVELOPING COUNTRY; FEASIBILITY STUDY; GHANA; GLAUCOMA; HEALTH CARE COST; HUMAN; INCIDENCE; MIDDLE AGED; PATHOPHYSIOLOGY; PREVALENCE; REPRODUCIBILITY; SENSITIVITY AND SPECIFICITY; STATISTICAL MODEL; VISUAL FIELD;

ADULT; AGED; AGED, 80 AND OVER; BARBADOS; COST OF ILLNESS; COST-BENEFIT ANALYSIS; DEVELOPING COUNTRIES; FEASIBILITY STUDIES; GHANA; GLAUCOMA; HEALTH CARE COSTS; HUMANS; INCIDENCE; MIDDLE AGED; MODELS, ECONOMIC; PREVALENCE; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; VISUAL FIELDS;

EID: 78651500188     PISSN: 10405488     EISSN: None     Source Type: Journal    
DOI: 10.1097/OPX.0b013e3181fc30f3     Document Type: Article

References (39)

1. Cook J, Frick KD, Batussen R, Resnikoff S, Smith A, Mecaskey A, Kilima P. Loss of vision and hearing. In: Jameson DT, et al, eds. Disease Control Priorities in Developing Countries. Washington, DC: The World Bank; 2006:953-62.
2. Resnikoff S, Pascolini D, Etya'ale D, Kocur I, Pararajasegaram R, Pokharel GP, Mariotti SP. Global data on visual impairment in the year 2002. Bull World Health Organ 2004;82:844-51.
3. World Health Organization. Global Burden of Disease in 2002: Data Sources, Methods and Results. Geneva: World Health Organization; 2004.
4. Leske MC, Connell AM, Schachat AP, Hyman L. The Barbados Eye Study. Prevalence of open angle glaucoma. Arch Ophthalmol 1994; 112:821-9.
5. Leske MC, Connell AM, Wu SY, Nemesure B, Li X, Schachat A, Hennis A. Incidence of open-angle glaucoma: the Barbados Eye Studies. The Barbados Eye Studies Group. Arch Ophthalmol 2001;119:89-95.
6. Ntim-Amponsah CT, Amoaku WM, Ofosu-Amaah S, Ewusi RK, Idirisuriya-Khair R, Nyatepe-Coo E, Adu-Darko M. Prevalence of glaucoma in an African population. Eye (Lond) 2004;18:491-7.
7. Egbert PR. Glaucoma in West Africa: a neglected problem. Br J Ophthalmol 2002;86:131-2.
8. Harris KA, Thacker CR, Ballard D, Harrison C, Musgrave-Brown E, Syndercombe Court D; SNP for ID Consortium. An investigation into the genetic structure of a Barbadian population. In: Amorim A, Corte-Real F, Morling N, eds. Progress in Forensic Genetics 11: Proceedings of the 21st International ISFG Congress held in Ponta Delgada, The Azores, Portugal Between 13 and 16 September 2005. Boston: Elsevier; 2006:412-4.
9. World Health Organization. Making Choices in Health: WHO Guide to Cost-Effectiveness Analysis. Geneva: World Health Organization; 2003.
10. Rein DB, Wittenborn JS, Lee PP, Wirth KE, Sorensen SW, Hoerger TJ, Saaddine JB. The cost-effectiveness of routine office-based identification and subsequent medical treatment of primary open-angle glaucoma in the United States. Ophthalmology 2009;116:823-32.
11. Leske MC, Heijl A, Hussein M, Bengtsson B, Hyman L, Komaroff E. Factors for glaucoma progression and the effect of treatment: the early manifest glaucoma trial. Arch Ophthalmol 2003;121:48-56. (Pubitemid 36401765)
12. Heijl A, Leske MC, Bengtsson B, Hyman L, Hussein M. Reduction of intraocular pressure and glaucoma progression: results from the Early Manifest Glaucoma Trial. Arch Ophthalmol 2002;120:1268-79.
13. Centers for Disease Control and Prevention. National Center for Health Statistics. Publications and Information Products. NCHS Health E-Stat: Asthma Prevalence, Health Care Use and Mortality; 2002. Available at: http://www.cdc.gov/nchs/data/hestat/asthma/asthma.htm. Accessed September 3, 2010.
14. Soltau JB, Zimmerman TJ. Changing paradigms in the medical treatment of glaucoma. Surv Ophthalmol 2002;47(Suppl. 1):S2-5.
15. Perry CM, McGavin JK, Culy CR, Ibbotson T. Latanoprost: an update of its use in glaucoma and ocular hypertension. Drugs Aging 2003;20:597-630.
16. Zhou Z, Althin R, Sforzolini BS, Dhawan R. Persistency and treatment failure in newlydiagnosed open angle glaucoma patients in the United Kingdom. Br J Ophthalmol 2004;88:1391-4.
17. Reardon G, Schwartz GF, Mozaffari E. Patient persistencywith topical ocular hypotensive therapy in a managed care population. Am J Ophthalmol 2004;137:S3-12.
18. Ederer F, Gaasterland DA, Dally LG, Kim J, VanVeldhuisen PC, Blackwell B, Prum B, Shafranov G, Allen RC, Beck A; AGIS Investigators. The Advanced Glaucoma Intervention Study (AGIS): 13. Comparison of treatment outcomes within race: 10-year results. Ophthalmology 2004;111:651-64.
19. Harper R, Reeves B. The sensitivity and specificity of direct ophthal-moscopic optic disc assessment in screening for glaucoma: a multi-variate analysis. Graefes Arch Clin Exp Ophthalmol 2000;238:949-55.
20. Sommer A, Enger C, Witt K. Screening for glaucomatous visual field loss with automated threshold perimetry. Am J Ophthalmol 1987;103:681-4.
21. Sponsel WE, Ritch R, Stamper R, Higginbotham EJ, Anderson DR, Wilson MR, Zimmerman TJ. Prevent Blindness America visual field screening study. The Prevent Blindness America Glaucoma Advisory Committee. Am J Ophthalmol 1995;120:699-708.
22. Rein DB, Wirth KE, Johnson CA, Lee PP. Estimating quality-adjusted life year losses associated with visual field deficits using methodological approaches. Ophthalmic Epidemiol 2007;14: 258-64.
23. World Health Organization (WHO). CHOosing Interventions that are Cost Effective (WHO-CHOICE): Country Specific Costs. Available at: http://www.who.int/choice/country/en/index.html. Accessed September 3, 2010.
24. American Medical Association. CPT 2006: Current Procedural Terminology, Standard edition. Chicago, IL: Thomson Delmar Learning; 2007. Available at: https://catalog.ama-assn.org/Catalog/cpt/cpt-search.jsp?checkXwho=done. Accessed September 3, 2010.
25. International Drug Price Indicator Guide. International Drug Price Indicator Guide. Drug Price Search. Available at: http://erc.msh.org/dmpguide. Accessed September 3, 2010.
26. RedBook: Pharmacy's Fundamental Reference. Montvale, NJ: Thomson PDR; 2007.
27. Edejer TT-T, Baltussen R, Adam T, Hutubessy R, Acharya A, Evans DB, Murray CJL, eds. Making Choices in Health: WHO Guide to Cost-Effectiveness Analysis. Geneva: World Health Organization; 2003.
28. Frick KD, Foster A, Bah M, Faal H. Analysis of costs and benefits of the Gambian Eye Care Program. Arch Ophthalmol 2005;123: 239-43.
29. United Nations Development Programme. UN Human Development Report 2006: Beyond Scarcity: Power, Poverty and the Global Water Crisis. New York: United Nations Development Programme; 2006. Available at: http://hdr.undp.org/en/media/ HDR06-complete.pdf. Accessed September 3, 2010.
30. Thomas M, Wint E. Inequality and poverty in the eastern Caribbean. Proceedings of ECCB Seventh Annual Development Conference, 21-22 November 2002, Basseterre, St. Kitts. Barbados. West Indies: Caribbean Development Bank; 2002. Available at: http://www.caribank.org/titanweb/cdb/webcms.nsf/AllDoc/ 0BD1FCA9B25F2DBB042574lE0053033E/$File/inequalityand poverty%5B1%5D.pdf. Accessed September 3, 2010.
31. American Academy of Ophthalmology. Preferred Practice Patterns Committee, Glaucoma Panel. Primary Open-Angle Glaucoma. San Francisco, CA: American Academy of Ophthalmology; 2006.
32. Danias J, Podos SM. Comparison of glaucomatous progression between untreated patients with normal-tension glaucoma and patients with therapeutically reduced intraocular pressures. The effectiveness of intraocular pressure reduction in the treatment of normal-tension glaucoma. Am J Ophthalmol 1999;127:623-5.
33. U.S. Census Bureau. U.S. Census International Database. Available at: http://www.census.gov/ipc/www/idb. Accessed September 3, 2010.
34. World Health Organization (WHO). Health Statistics and Health Information Systems. Life Tables for WHO Member States. Available at: http://apps.who.int/ whosis/database/life-tables/life-tables.cfm. Accessed September 3, 2010.
35. Central Intelligency Agency. The World Factbook. Available at: https://www.cia.gov/library/publications/the-world-factbook/index.html. Accessed September 3, 2010.
36. US. Census Bureau Population Division. National Population Projections. In: (NP-T4-A) Projections of the Total Resident Population by 5-Year Age Groups, Race, and Hispanic Origin with Special Age Categories: Middle Series, 1999 to 2000. Available at: http://www.census.gov/population/projections/nation/summary/ np-t4-a.pdf. Accessed September 3, 2010.
37. Weinstein MC, O'Brien B, Hornberger J, Jackson J, Johannesson M, McCabe C, Luce BR. Principles of good practice for decision analytic modeling in health-care evaluation: report of the ISPOR Task Force on Good Research Practices - Modeling Studies. Value Health 2003; 6:9-17.
38. Hyman L, Wu SY, Connell AM, Schachat A, Nemesure B, Hennis A, Leske MC. Prevalence and causes of visual impairment in The Barbados Eye Study. Ophthalmology 2001;108:1751-6.
39. Sachs J. Macroeconomics and Health: Investing in Health for Economic Development. Geneva: World Health Organization; 2001.